Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis (original) (raw)
The Evolving Concept of Poor-Prognosis for Women Undertaking IVF and the Notion of Growth Hormone as an Adjuvant; A Single-Center Viewpoint
John Yovich
Frontiers in Endocrinology
View PDFchevron_right
The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomized control trial
Mohamed Hassan
European journal of obstetrics, gynecology, and reproductive biology, 2018
View PDFchevron_right
Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve
Roger Hart
Frontiers in Endocrinology
View PDFchevron_right
Live birth outcomes of vitrified embryos generated under growth hormone stimulation are improved for women categorized as poor-prognosis
John Yovich
Clinical and Experimental Reproductive Medicine
View PDFchevron_right
Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF
John Yovich
Reproductive BioMedicine Online, 2010
View PDFchevron_right
The Concept of Growth Hormone Deficiency Affecting Clinical Prognosis in IVF
SYEDA SUMMIKA ZAIDI
Frontiers in Endocrinology, 2019
View PDFchevron_right
Low Dose Growth Hormone Adjuvant Treatment With Ultra-Long Ovarian Stimulation Protocol in Poor Responders Showed Non-inferior Pregnancy Outcome Compared With Normal Responders
Chii-ruey Tzeng
Frontiers in Endocrinology, 2019
View PDFchevron_right
Efficacy of Growth Hormone Supplementation with Gonadotrophins in IVF/ICSI for Poor Responders; Randomized Controlled Trial
Mohamed Shafeek
2019
View PDFchevron_right
The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response
Merve Demir
Journal of Gynecology Obstetrics and Human Reproduction, 2021
View PDFchevron_right
DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis
John Yovich
Frontiers in Endocrinology
View PDFchevron_right
Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF/ICSI for poor responders; randomized controlled trial
Mohamed Shafeek
Taiwanese journal of obstetrics & gynecology, 2021
View PDFchevron_right
New Criteria for the Use of Growth Hormone in the Treatment of Female Infertility: Minireview and a Case Series
Jan Tesarik
EC Gynaecology, 2020
View PDFchevron_right
Is growth hormone administration essential for in vitro fertilization treatment of female patients with growth hormone deficiency?
Alice Albu
Systems biology in reproductive medicine, 2018
View PDFchevron_right
Effect of growth hormone on oocyte competence in patients with multiple IVF failures
Y. Ménézo
Reproductive BioMedicine Online, 2009
View PDFchevron_right
Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?
Marc Germond
Human Reproduction, 1999
View PDFchevron_right
Adjuvant growth hormone use improves euploid rate in women undergoing IVF/PGT-A who are not poor responders
winifred mak
Fertility and Sterility, 2019
View PDFchevron_right
Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone
André Hazout
Human Reproduction, 2005
View PDFchevron_right
Impact of Ovarian Yield—Number of Total and Mature Oocytes Per Antral Follicular Count—On Live Birth Occurrence After IVF Treatment
Achraf BENAMMAR
Frontiers in Medicine, 2021
View PDFchevron_right
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature
Antonio Bianchi
Fertility and Sterility, 2009
View PDFchevron_right
Women Older Than 40 Years of Age and Those With Elevated Follicle-Stimulating Hormone Levels Differ in Poor Response Rate and Embryo Quality in In Vitro Fertilization
Frank Broekmans
Obstetrical Gynecological Survey, 2003
View PDFchevron_right
Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial
Tansu Kucuk
Journal of Assisted Reproduction and Genetics, 2008
View PDFchevron_right
Follicle Stimulating Hormone and Anti-Müllerian Hormone per Oocyte in Predicting in vitro Fertilization Pregnancy in High Responders: A Cohort Study
olusegun K ajenifuja
PLoS ONE, 2012
View PDFchevron_right
Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization
Hong-Nerng Ho
Fertility and Sterility, 2003
View PDFchevron_right
In Vitro Fertilization Success and Associated Factors: A Prospective Cohort Study
Forough Mortazavi
2018
View PDFchevron_right
In-Vitro Fertilization Outcome Predictors in Women With High Baseline Follicle-Stimulating Hormone Levels: Analysis of Over 1000 Cycles From A Tertiary Center
Aysin Akdogan
JBRA Assisted Reproduction
View PDFchevron_right
Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization
MARTHA LUNA
Fertility and Sterility, 2007
View PDFchevron_right
FSH/LH Ratio as a Predictor of the IVF Outcome in Young Women
AHMED MAGED
Open Journal of Obstetrics and Gynecology, 2018
View PDFchevron_right
The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone
Karen Elkind-hirsch
Fertility and Sterility, 2008
View PDFchevron_right
The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization
Anna Legedza
Journal of assisted reproduction and genetics, 2000
View PDFchevron_right
Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
David Albertini
Journal of translational medicine, 2016
View PDFchevron_right
Is bigger better: the association between follicle size and livebirth rate following IVF
Christine Mullin
Fertility and Sterility, 2010
View PDFchevron_right
A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer
Randal Robinson
Fertility and Sterility, 2006
View PDFchevron_right
Randomized controlled trial comparing embryonic quality in rFSH versus hMG in IVF protocol with GnRH Antagonist
Rita Chapon
JBRA Assisted Reproduction
View PDFchevron_right